EMA — authorised 28 August 2008
- Status: approved
🇪🇺 Intelence in European Union
EMA authorised Intelence on 28 August 2008
Marketing authorisation
Intelence in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Intelence approved in European Union?
Yes. EMA authorised it on 28 August 2008.
Who is the marketing authorisation holder for Intelence in European Union?
Janssen R And D is the originator. The local marketing authorisation holder may differ — check the official source linked above.